{
  "actions": [
    {
      "acted_at": "2008-06-18", 
      "references": [
        {
          "reference": "CR S5760", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2008-06-18", 
      "committee": "Committee on Health, Education, Labor, and Pensions", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s3151-110", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "110", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Brownback, Sam", 
      "sponsored_at": "2008-06-18", 
      "state": "KS", 
      "thomas_id": "00137", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2008-06-18", 
  "number": "3151", 
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to priority review vouchers.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": null, 
    "name": "Brown, Sherrod", 
    "state": "OH", 
    "thomas_id": "00136", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2008-06-18", 
  "subjects": [
    "Cholera", 
    "Communicable diseases", 
    "Diseases", 
    "Drug approvals", 
    "Health", 
    "Leprosy", 
    "Malaria", 
    "Tuberculosis"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2008-06-18", 
    "text": "Amends the Federal Food, Drug, and Cosmetic Act to require that priority review vouchers, which are given by the Secretary of Health and Human Services to the sponsor of a tropical disease product application, are transferable to sponsors of human drug applications for approval of a new drug or biological product. Prohibits such vouchers from being redeemed to affect the review of a pending human drug application."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to priority review vouchers.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:44:15-05:00"
}